This Week in Psychedelics - 11.26.21

Cannabis

  • The new German government plans to legalize cannabis. (The New York Times)

  • Mexico Senate on Track to Endorse Recreational Cannabis by December (High Times)

  • Uber Eats users in Ontario can now buy cannabis through the app (Engadget)

  • New GOP weed approach: Feds must ‘get out of the way’ (Politico)

  • South Dakota Supreme Court kills adult-use legalization (Leafly)

  • Is Fentanyl-Tainted Marijuana 'Something Real' or 'Just an Urban Legend'? (Reason)

  • A New Center at CSU Aims to Unlock the Secrets of CBD (5280)

  • Indica and sativa labels are largely meaningless when it comes to cannabis complexities (The Conversation)

  • St. Louis Lawmakers Unanimously Approve Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)

  • Analysis: Marijuana Legalization Associated with Improved Clearance Rates for Violent Crimes (NORML)

  • Illinois Judge Rules Weed Odor is Not Probable Cause For Searches (High Times)

  • Ohio Marijuana Activists Almost Have Enough Signatures To Force Lawmakers To Consider Legalization (Marijuana Moment)

  • New Mexico Issues First Adult-Use Cannabis Cultivation License (High Times)

  • Taliban Contracts Australian Company To Grow Cannabis In Afghanistan (Marijuana Moment)

  • Mississippi lawmakers unlikely to reach medical marijuana deal this year (Marijuana Business Daily)

  • Dogs Are Being Exposed To Marijuana Through Human Poop And Pet Owners Should Beware, Study Finds (Marijuana Moment)

  • Majority Of Texas Republicans Back Marijuana Legalization, Poll Finds (Marijuana Moment)

  • Arizona Cannabis Social Equity Program Faces Legal Challenge (High Times)

  • Canada’s first regulated cannabis suppositories target female consumers (Marijuana Business Daily)

  • Montana: Officials Create New Drug Court to Focus Solely on Expunging Past Marijuana Convictions (NORML)

  • Few Medical Cannabis Licenses in Portugal Have Been Awarded (High Times)

  • Pennsylvania order targeting vaporized products upends cannabis market (Marijuana Business Daily)

  • CNN’s Sixth WEED Documentary Features the Benefits of Medical Cannabis for Autism (High Times)

LSD

  • New graphic novel depicts famed history of LSD research in Sask. (CBC)

Magic Mushrooms

  • Magic mushroom study hints psilocybin repairs alcohol-induced brain damage (Inverse)

  • COMPASS Pathways granted fifth US patent for crystalline psilocybin (Psilocybin Alpha)

  • Metaphysics and mushrooms: Psychedelics can change how you think about the universe (Big Think)

  • What Happens When Zen Monks Take Mushrooms? (Lucid News)

  • HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada (Psilocybin Alpha)

MDMA

  • Police Presence at Music Festivals Linked to "Panic Overdoses": Study (EDM)

DMT

  • Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs (Psilocybin Alpha)

Ayahuasca

  • Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony (PsyPost)

  • Are All Ayahuasca Retreats The Same? You Might Be Surprised (Healing Maps)

Peyote

  • Mining and Poaching Threatens 15,000-Year-Old Peyote Tradition in Mexico (DoubleBlind)

San Pedro

  • San Pedro: What is it Like to Experience Mescaline from San Pedro? (The Third Wave)

Novel Psychoactive Substances

Ketamine

  • Ketamine benefits neurocognition in depression with suicidal ideation (Healio)

  • Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments (Psilocybin Alpha)

  • PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus (Psilocybin Alpha)

  • Navigating the Patchwork of New York City Ketamine Clinics (Lucid News)

Miscellaneous

  • New Zealand Permanently Legalizes Drug Checking, a Global First (Filter)

  • U.S. Reports More Than 100,000 Overdose Deaths In One Year (High Times)

  • New study finds 'microdosing' psychedelics can be effective in treating anxiety, depression (The Hill)

  • Responding to the 2022 Global Drug Survey Will Help Other Drug Users (Filter)

  • Colorado Springs Pushing to Decriminalize Psychedelics (Truffle Report)

  • The Rise of Psychedelic Retreats (The New York Times)

  • How to Cultivate a More Ethical, Inclusive Psychedelic Future (Lucid News)

  • Why Are Some People More Sensitive to Psychedelics Than Others? (Sam Woolfe)

  • Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities (Psilocybin Alpha)

  • Academic Centers Start to Take Psychedelics Seriously (Medpage Today)

  • Psychedelics and Mysticism: The Debate Continues (Psychedelic Science Review)

  • Psychedelics, Cognition, and Sleep Disorders (Truffle Report)

  • Is Psychedelic Research Funding Starting to Shift? (Medpage Today)

  • Revive Therapeutics Files for ODD Designation for Bucillamine Treatment Targeting Rare Liver Disorders, COVID-19 (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.